Insider Transactions Reported by 8 Insiders of Actinium Pharmaceuticals, Inc.

Symbol
ATNM on NYSE
Location
New York, NY

There are no Buy or Sell transactions made by insiders since 11 Feb 2025

Actinium Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sandesh Seth Chief Executive Officer, Director $315,462 18 Aug 2025
C. David Nicholson Director 31 Mar 2025
June Sherie Almenoff Director 31 Mar 2025
Ajit Shetty Director 31 Mar 2025
Richard Steinhart Director 31 Mar 2025
Steve O'Loughlin Chief Financial Officer 31 Mar 2025
Jeffrey W. Chell Director 31 Mar 2025
Mark Berger Chief Medical Officer 01 Sep 2021

Recent Insider Transactions by Companies or Individuals for Actinium Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.